Judith Steinhart

 

I Had the Honor of Officiating at a Wonderful Wedding!

The New York Times
http://www.nytimes.com/2009/06/07/fashion/weddings/07vows.html
Vows

Anya Emerson and Jonah Staw

Peter DaSilva for The New York Times

NAVARRO, CALIF., MAY 24 The couple received flowers for her bouquet. By DEVAN SIPHER   Published: June 6, 2009

NOTHING matches, but anything goes.

Peter DaSilva for The New York Times        
Later, they faced a wedding-cake-shaped piñata.

That’s the slogan of LittleMissMatched, an offbeat New York clothing firm that sells unmatched socks in vibrant color-coordinated patterns. It is also in many ways the outlook of the company’s chief executive and co-founder, Jonah Staw.

“I’ve never dealt well with rules,” said Mr. Staw, with self-aware humor. “I have a fear of being constrained.”

So it may be unsurprising that he was dating Anya Emerson for more than six years before they became engaged. Even then, it was Ms. Emerson who asked for his hand in marriage.

His mother, Jane Anne Staw, said Mr. Staw was very independent “ starting from birth,” the kind of kid who was out of the house almost as soon as he could walk.

A budding entrepreneur at 5, Mr. Staw had a garage sale for his unused toys, and at 8 he sold handmade postcards to local stores in Oakland, Calif.

In contrast, Ms. Emerson, 31 and a lawyer at the nonprofit New York Legal Assistance Group, is by nature and profession a rules follower. But, she said, “I appreciate being with someone who encourages me to break a rule or take a chance.”

The couple, who both attended the same Oakland high school, first spoke in 2001 at an alumni Christmas party. “It was a disaster,” Mr. Staw, 33, recalled of his initial flirtation. His brash and breezy style flamed out when countered by her cautious cool-headedness.

“Anya is elusive,” he said, noting that unlike himself she didn’t feel compelled to charm strangers. “She saves a piece of who she is for people she cares about.”

He persisted, and after the intervention of mutual friends she relinquished her e-mail address. But she remained hesitant, because after the holidays she was returning to Ecuador, where she was a volunteer English teacher.

Still, she said she found Mr. Staw, a magna cum laude graduate of Brown, cute and intriguing. They managed to squeeze in two dinner dates in one week. “I can’t remember being ever so attracted to someone,” he said.

Once back in Quito, Ecuador, Ms. Emerson said she couldn’t stop thinking about him. So for their third date, she invited him on a 10-day trip to Peru.

“In my relationships before Anya, I was always the one challenging my partners,” said Mr. Staw, who was excited by her risk-taking. So much so, that it wasn’t until his arrival at the Lima airport in February that he questioned his own derring-do.

“You think you know someone a little bit because you spent two nights having dinner, and you realize you don’t know anything about them,” he said.

They quickly learned that they had very different travel styles. Ms. Emerson likes to read guidebooks cover to cover, and Mr. Staw prefers to wing it.

But they were united as they hiked in the tropical forest encountering kaleidoscopic orchids along the Inca Trail, and they stood in awed embrace as the glory of Machu Picchu spread out before them.

By the end of the trip, she had fallen in love with him, but she wasn’t sure if he felt the same.

In July, having completed her teaching stint, Ms. Emerson moved back to the Bay Area, and they started spending much of their time together. Only a couple of months later she suffered a severe repetitive stress injury from typing. Her wrists were put in plastic casts, and she needed Mr. Staw’s assistance with dressing and other basic daily functions.

“Jonah was freaking out about what he got himself into,” she said, while she resented needing his help. Ms. Emerson, who graduated with distinction from Stanford and has a master’s in history from Oxford, prided herself on her intellectual and physical autonomy. “I was pretty mad at him, because I was the one whose life was in crisis, not him,” she said.

“My first instinct was flight,” Mr. Staw conceded. “I was scared and uncomfortable, but I’m stubborn and strong-willed, too.” So he wasn’t going to give up on someone he realized he loved. “I would have been the ultimate failure if I had run away.”

He did not, and her symptoms abated. They officially moved in together in January 2004, before relocating to New York, where she attended law school at Columbia.

By 2008, she had passed the bar, and they had lived together more than four years. “I was tired of calling him my boyfriend,” Ms. Emerson said. “I didn’t think that described our relationship well enough.”

She said she thought that it was undignified to drop hints to get him to propose, and she doubted that he would volunteer to be legally bridled. So she decided it was time for some rule-breaking of her own, and it was Ms. Emerson who got down on one knee as they hiked in the Catskills last April.

“It felt like I was loved in a tremendously honest and pure way,” he said, recalling his surprise and ardent gratitude. “She was making it easy for me. All I had to do was say yes.”

On May 24, they were joined by 175 friends and family members under a vault of blue sky in the northern California town of Navarro, where many of their guests had helped the couple build a hilltop vacation home.

Mr. Staw, in mismatched socks, contentedly held Ms. Emerson’s hand beneath a wedding canopy. The bride stood stately and erect, echoing the Redwoods that surrounded them as Judith Steinhart, a Universal Life minister, led them in their vows.

“Just a month ago, Jonah and Anya, didn’t know they could see to the far end of the valley,” Ms. Steinhart said, referring metaphorically and literally to a recent clearing of scrub brush on the property. “You just have to be open to the possibilities.”

After dining on tacos and tamales, their guests toasted and roasted the couple, zeroing in on the bridegroom’s boyhood penchant for T-bills over T-ball.

“I am a materialist who cares about money, and Anya’s all about giving back,” Mr. Staw happily acknowledged. “Mismatching is the ultimate match.”

Louise Rafkin contributed to this article.

Comments [0]

Big Beautiful Women vs. Invented, Unnecessary, Discriminatory Obstacles to Beauty and Style! Plus Some Real Finds!

I wrote but didn't post this before Crains article came out....
http://www.crainsnewyork.com/article/20090531/FREE/305319991

Then I found this:  The New York Post had a summary of this article

http://www.nypost.com/seven/06012009/news/nationalnews/stores_ditch_big_size_duds_171902.htm with a terrible first sentence and some terrific comments by readers.

The New York Times will have a similar article with a different perspective this week.  So my thoughts, and my expereinces, are timely!

Here it is: 

How can women be expected to celebrate their body when there are so many barriers?
70% of American women are size 12 or above.

Where do they shop? Where and how do they find fab styles and terrific looks?
Where are the stores with a large, huge, generous, ample, broad selection of fashionable, fitted, stylish clothing made with natural fibers that don't shrink, and fit big, curvy women?

Clothes for big women are often whimpy pastels, baby pink, baby blue, super large patterns, with large ruffles, unflattering short sleeve lengths, made the way maternity clothes were made in the '50s.

Clothing stores are no longer carrying larger sizes. The famous Loehman 's opened their NYC Upper West Side store with no larger sizes. I was told that only their 7th Avenue location in NYC carried larger sizes. When I went in last week, I learned from a salesperson that Loehman's 7th Avenue location no longer carries larger sizes, and hasn't for months.

The Gap and Banana Republic no longer carry size 16 in the stores. Only online.
Ann Taylor no longer makes size 16 available in the stores. Only on-line.

Are these merchants ashamed that or embarrassed about larger women frequenting their stores?  Do they think larger women stay at home hiding behind their computers, and order clothing online, with money to burn for mail order and returns?
 
Even in specialty stores, (Lane Bryant, Avenue), larger size outfits are cut in boxy shapes, as if women were shaped without curves, or as though the curves needed to be covered up.  These hide-your-body clothes, similar to muumuus, masses of shapeless fabric, render women shapeless, curveless or blob-like, rather than marvelous, sexy, elegant, professional, or hip.

And don't even get me started about bras! There's plenty of material for another blog....

Ok, The Good News!

Recently, I did find and fit into terrific pants in brown, on sale at Talbots, (http://www.talbots.com) in the misses, not women's, sale rack.
I also found perfect linen and also denim capris on sale at Lane Bryant, and some cotton tops (a bit too boxy, but they'll do).

Now, The GREAT News!!!!

And while visiting San Francisco, Randi, my good friend, fellow shopper, (Randi has STYLE), and generous hostess, and I stopped into a hidden gem! Go Figure (http://www.gofigure.com) in the Richmond.  Great selection gawjus clothes, sensuous fabrics. Yes, the prices are a bit higher, but the selection was broad and varied, full of natural fibers, fitted and not so fitted styles, with a warm, smiling, curvy woman with style and a smile, ready to pitch in a get to work with me.  For the icing on the cake, they had a terrific sale rack. I bought a reversible burgundy to black, solid color, down-like jacket, with a hood, that looks and fastens like a short kimono.  It comes with a matching carry-on bag.  I'll see if I can take a photo to add to this blog. Randi also tried on tops and jackets that rocked the house!

I wish I lived closer, or that they had an east coast branch.  But you can buy through the mail.

In the meantime, if you need help, I would suggest contacting two NYC based stylists:

I feel privileged, and lucky, to have found them both, and I personally guarantee your wardrobe and attitude will be in good shape and in good hands, when working with them.

Let me know what you learn and find, and where you find it!
Thinking of you, all of you, bigger you are, the more there is to rock,
Jud
(check out, http://www.heyjud.com, my relationship and sexuality Q&A blog)

Comments [0]

New Sexuali-Tea! A Tea-rific Time!

This was the invitation:

Body, Sex, and Soul - An Afternoon Tea for Women on the Last Sunday in May

Conversation, presentation,  inspiration for our two hour getaway.......among our women friends.   

Three experts to share their stuff in an intimate afternoon of care, laughter, creativity.  Brief 20-minute presentations from Dr. Sezelle Haddon, ENT specialist with an emphaisis on alternative and complementary medicine, on the Body, Clinical Sexologist/Relationship Coach Judith Steinhart, (www.judithsteinhart.com) on Sexuality, and Author, Anthropologist, and Artist Gina Bria on the Soul, will be interspersed with time for questions, reflection, conversation, and a meditative, creative project.  Leave with new fuel for living, new friends and a completed art piece.  Who could resist? Teas served with beautiful, bountiful nibbles that inspire health. 


This invitation was sent out for our newest collaboration, and twenty women joined us for a memorable event!  What a mix of women-- writers, anthropologists, sexuality educators, women's health advocates, moms, single, partnered women, all ages, from Brazil and from Brooklyn.  We talked, danced salsa, wrote something like poems, made art using paint, and thought about things in different ways.  Gina created a warm, welcoming atmosphere, and wonderful healthy, light foods that no one knew were healthy, and tea selection was Tea-lightful.


Bianca and I will be making zines with the poems and art, so we will have tangible results from our afternoon Tea-light to send to the participants.


Hope to see you at the next one.  Just sign up for Jud's News on www.judithsteinhart.com to keep informed and invited!


Thinking of you,

Jud

Comments [0]

Where ARE the Wild Things???? Ask President Obama, He Knows!

Comments [0]

Spray to Delay Ejaculation.... But read the fine print.... or rather the BOLD print....

Topical Spray Helped Men With Premature Ejaculation

Healthday.com

http://www.healthday.com/" mce_style="color: #0058a6; text-decoration: none; outline-width: 0px; outline-style: initial; outline-color: initial; float: left; margin-top: -6px; " mce_href="http://us.rd.yahoo.com/dailynews/hsn/SIG=10r2efrkl;_ylt=AizQyGdwkZQHq8JOo8bEw1OG_aF4;_ylu=X3oDMTEzZWUyZG0yBHBvcwMxBHNlYwN5bi1wcnZkbGluawRzbGsDaGVhbHRoZGF5/*http://www.healthday.com/" style="color: rgb(0, 88, 166); text-decoration: none; outline-width: 0px; float: left; margin-top: -6px;">

Mon Apr 6, 11:49 pm ET

MONDAY, April 6 (HealthDay News) -- A new spray enabled men with premature ejaculation to delay their orgasm six times longer than before, according to a study that included 300 European men.

The men, with clinically diagnosed premature ejaculation, were randomly selected to receive a placebo spray with no active ingredients (100 men) or the PSD502 spray, which contains 7.5 milligrams of lidocaine and 2.5 mg of prilocaine (200 men).

During the three-month study, the men used either the placebo or the PSD502 spray five minutes before intercourse. The men and their partners then used a stopwatch to record the time from vaginal penetration to ejaculation. The men were instructed to abstain from sexual activity or masturbation for 24 hours before each recorded episode of intercourse.

The men who used the PSD502 spray (treatment group) delayed their orgasm from an average of 0.6 minutes to 3.8 minutes, compared to just over 1 minute for those who used the placebo spray. That means the PSD502 spray helped men last 6.3 times longer than normal, compared to 1.7 times longer than normal for those who used the placebo, the study authors said.

The study found that after three months of treatment:

  • 90 percent of the men in the treatment group were able to delay ejaculation for more than 1 minute following vaginal penetration, compared with 54 percent of those in the placebo group.
  • 74 percent of men in the treatment group were able to last 2 minutes before ejaculation, compared with 22 percent of those in the placebo group.
  • 62 percent of men in the treatment group said their orgasms were "good" or "very good" after three months, compared with 20 percent before the start of the study. For men in the placebo group, the figures were 19 percent at the end of the study and 21 percent before the start of the study.
  • More patients and partners in the treatment group reported improvements in perceived control, personal distress, satisfaction with sexual intercourse, and interpersonal problems.

The most common problems noted in the study were loss of erection and a burning sensation in the vagina. 

The study findings were published in the April issue of the journal BJU International.

"Premature ejaculation can be a very distressing condition for men and can cause distress, frustration and make them avoid sexual intimacy," lead researcher Professor W. Wallace Dinsmore, of the Royal Victoria Hospital in Belfast, U.K., said in a news release.

"Our study shows that when the PSD502 spray was applied to the man's penis five minutes before intercourse it improved both sexual performance and sexual satisfaction, which are key factors in treating premature ejaculation.

            *******************************************************************************************************************************

If the most common problems were loss of erection and burning in the vagina, then WHAT IS THE POINT?

Plus, where is the pleasure?  Were these results at the expense of pleasure?  And whose pleasure is being sacrificed?

Yes, there are other effective NON-MEDICAL for a man to last longer.  This doesn't have to be one.

Thinking of you,
Jud

Comments [0]

Searching for the Female Viagra.... Why? I Ask? Women Don't Need Erections! They Want Pleasure! Go Leonore!


 
Philly.com
   
 
Click Here to Print
 http://www.savethis.clickability.com/st/saveThis?partnerID=166721&urlID=401829201&origin=11';,'click','height=450,width=510,title=no,location=no,scrollbars=yes,menubars=no,toolbars=no,resizable=yes'));">SAVE THIS | http://www.emailthis.clickability.com/et/emailThis?clickMap=createPT&partnerID=166721&urlID=401829201';,'click','height=450,width=510,title=no,location=no,scrollbars=yes,menubars=no,toolbars=no,resizable=yes'));">EMAIL THIS | Close 
 
 
Posted on Sun, Apr. 26, 2009


Drug firms keep up search for female Viagra

By Marie McCullough

Inquirer Staff Writer

The pharmaceutical industry's push to find a female version of Viagra has been full of letdowns.

Despite a decade of testing pills, patches, gels, nasal sprays, and vaginal rings, there is still no approved drug for "female sexual dysfunction." More than a dozen drugs that reached late-stage testing have been abandoned, shelved, or recycled for unrelated problems.

Market analysts still see multibillion-dollar opportunity in female sexual complaints. And two drugs - LibiGel and Flibanserin - doggedly aspire to become the first to win the FDA's imprimatur.

But female sex disorders have turned out to be far more difficult to define and quantify, let alone fix, than erectile dysfunction.

Kathy Kelley, the Texas founder of HysterSisters, a Web site for women who have had hysterectomies, testified before the U.S. Food and Drug Administration about the clear-cut need for drug therapies.

But she also understands how complex and individual those needs are.

"The brain is a woman's primary sex organ," she said in an interview.

Different from men

With the 1998 approval of the first male impotence drug, entrepreneurs, researchers, and many members of the fairer sex began lusting after a "pink" version.

Indeed, the first drugs to be tested in women were blood-vessel dilating agents that included Viagra and Cialis. The hope was that women would follow the classic male model of sexual response - interest, arousal, orgasm.

They did not. Pfizer Inc.'s research showed that genital blood flow increased in Viagra-treated women as they watched erotic videos, but the arousal did not make them desire sex.

The complexity of female response has kindled intense debate. How to distinguish normal from abnormal, physiological from psychological, discontent from debilitation?

The answers have financial implications, especially as most drugs for women have been designed to be used regularly and indefinitely, not just as needed to prime the pump.

"In order to get insurance coverage, you have to prove this is a defined medical disorder that is really disrupting your life," said Leslie Sandberg, a market analyst at Trinity Partners in Waltham, Mass. "The vast majority of Viagra sales are cash pay; infrequently is it covered."

In 2000, the FDA issued preliminary guidelines to help companies plan human studies of drugs for female sexual complaints. The guidelines - still not finalized - reflected the consensus that had emerged among sex experts at industry-supported conferences around that time.

The FDA said that although "the definition of FSD continues to evolve," it "currently" has four "components:" decreased desire, decreased arousal, sexual pain, and orgasm difficulties.

A woman with any one of these is dysfunctional - but only if she feels "personal distress" about it. Sex experts had added distress to diagnostic criteria for female sexual dysfunction in 1998, publishing a report in the Journal of Urology and the Journal of Sex and Marital Therapy.

The addition was a recognition that some women are happy with sexual inactivity, but it also foreshadowed the challenge of treating a largely subjective disorder.

Diminished libido, now called hypoactive sexual desire disorder, is what most drugs have focused on. Effectiveness is judged by how many "satisfactory sexual events" the woman reports during the study period, typically three to six months. Unlike an erection, a satisfactory event is whatever the woman thinks it is, from cuddling to coitus.

In study after study, placebos increased satisfying events almost or just as much as the actual drug.

Poor performance was an issue with Intrinsa, the Procter & Gamble testosterone patch for women who experience "surgical menopause" after having their ovaries removed. In 2004, FDA advisers judged the product marginally effective, but rejected it because of a lack of safety data on long-term testosterone use.

P&G, which withdrew Intrinsa's U.S. application, won approval in numerous European countries. The product made just $2.5 million there last year, according to the information firm IMS Health. At that rate, P&G is a long way from recouping its costs; taking a new prescription drug to market costs hundreds of millions of dollars.

"I think the FDA put a pretty big wet blanket" on female sexual-dysfunction drug development, said Andrew Goldstein, a Washington obstetrician-gynecologist and president-elect of the International Society for the Study of Women's Sexual Health, founded in 2001.

Conflicting numbers

Another contentious challenge for the industry has been quantifying - critics would say exaggerating - how many women suffer from sexual disorders.

The most widely cited prevalence estimate is taken from a national survey published in 1999 in the influential Journal of the American Medical Association. The study found that 43 percent of American women ages 18 to 59 were sexually dysfunctional, compared with only 31 percent of men.

The really surprising thing, though, was that the rate wasn't higher. Here's what the survey, which did not inquire about personal distress, asked:

Over the past year, has there ever been a period of several months or more when you "lacked interest" in sex, or "didn't find pleasure" in it, or climaxed too quickly, or not at all, or found intercourse painful?

The results of the study - funded by the federal government and the Ford Foundation - became a staple of drug companies' efforts to raise awareness of the apparent epidemic of female sex disorders and the lack of drug remedies.

More recent surveys that included questions about distress found that 3 percent to 12 percent of women were sexually dysfunctional.

Yet the startling 43 percent statistic lives on.

Female Sexual Dysfunction Online, an educational Web site for doctors and researchers, offers several recent instructional presentations that cite that statistic. The Web site is supported by Intrinsa-maker Procter & Gamble and by Boehringer Ingelheim, which is developing Flibanserin.

The other company in the race for FDA approval is BioSante Pharmaceuticals. Last month, a news release about its testosterone gel, LibiGel, declared that "approximately 40 million American women suffer from some type of sexual disorder." Doing the math, that's 43 percent.

Lenore Tiefer, a psychologist and sex therapist at New York University, denounces this as "inflated epidemiology" calculated to make sexually healthy women worry that they're not.

For the last decade, she has led a widely reported campaign against what she calls "disease-mongering" by the drug industry and "agents of medicalization," such as publicists and gullible journalists. She promotes an alternative view of women's sexuality that stresses psychological, cultural, and relationship factors.

"I'm frustrated by how little of our positive understanding of sexuality has gotten out," she said.

Goldstein's rebuttal: "I think these people aren't talking to women who have the problem. Baby boomers came of age during the 'sexual revolution' and took ownership of their sexuality. . . . When they lose that, for some it's like losing a body part."

Accidental results

Goldstein is a consultant to Boehringer, the German company developing Flibanserin, a drug that acts on brain chemicals involved in mood. It was originally tested as an antidepressant until female subjects reported feeling no cheerier, just unexpectedly frisky.

Boehringer won't say how Flibanserin has performed, but it hopes to complete studies of premenopausal women with low libido this year, spokeswoman Lara Crissey said.

BioSante, meanwhile, readily shares a study in which its daily testosterone gel increased surgically menopausal women's satisfying sexual events an average of five per month - three more than a placebo.

Women make testosterone, the quintessential male hormone, in small amounts. It has always been a leading candidate for sexual therapy because for some women, it works. Prescription data show that several million of them order customized testosterone compounds from pharmacies or use men's testosterone therapies in lower doses.

However, prescriptions for all female hormones have plummeted in recent years because of a landmark federal study showing that the risks of estrogen-progestin therapy outweighed the benefits. Last month, Solvay Pharmaceuticals stopped making Estratest, a menopausal estrogen-testosterone product that had been prescribed for decades to boost female sex drive, even though it was not approved for that purpose.

The science and safety of female testosterone supplementation also remains unclear. In general, female libido declines with age, as does testosterone, yet blood levels of the hormone don't correlate with desire, arousal, or function, studies show.

"Despite some 70 years of clinical use, we do not have a fully satisfactory rationale for testosterone therapy," Canadian gynecologist and sex researcher Rosemary Basson wrote last year in the Annals of Internal Medicine.

BioSante is undaunted. After lengthy negotiations with the FDA, the Lincolnshire, Ill., firm is conducting an unprecedented safety study of 3,000 women to track the incidence of breast cancer and cardiovascular events such as heart attacks. The company plans to seek approval after 12 months - in late 2010 - but will follow the women for an additional four years, chief executive Stephen Simes said.

"Competition has fallen away, and we're pushing ahead," Simes said. "Why? Our company is dedicated to women's health. I think women deserve options."

He also thinks LibiGel, at $4 a day, will feel the love: "I'm confident it will be between a $500 million- and a $1 billion-a-year product."


Contact staff writer Marie McCullough at 215-854-2720 or mmccullough@phillynews.com.
 
 




Click Here to Print
 http://www.savethis.clickability.com/st/saveThis?partnerID=166721&urlID=401829201&origin=11';,'click','height=450,width=510,title=no,location=no,scrollbars=yes,menubars=no,toolbars=no,resizable=yes'));">SAVE THIS | http://www.emailthis.clickability.com/et/emailThis?clickMap=createPT&partnerID=166721&urlID=401829201';,'click','height=450,width=510,title=no,location=no,scrollbars=yes,menubars=no,toolbars=no,resizable=yes'));">EMAIL THIS | Close 
 Check the box to include the list of links referenced in the article.
 
 
© Copyright | Philly Online, LLC. All Rights Reserved. Any copying, redistribution or retransmission of any of the contents of this service without the express written consent of Philly Online, LLC is expressly prohibited.

Comments [0]

A Love Letter to My Friends-- And Yours!

Thank you for giving me so much!  Health, longevity, perspective, and your hearts.


The New York Times
April 21, 2009
Well

What Are Friends For? A Longer Life

By TARA PARKER-POPE

In the quest for better health, many people turn to doctors, self-help books or herbal supplements. But they overlook a powerful weapon that could help them fight illness and depression, speed recovery, slow aging and prolong life: their friends.

Researchers are only now starting to pay attention to the importance of friendship and social networks in overall health. A 10-year Australian study found that older people with a large circle of friends were 22 percent less likely to die during the study period than those with fewer friends. A large 2007 study showed an increase of nearly 60 percent in the risk for obesity among people whose friends gained weight. And last year, Harvard researchers reported that strong social ties could promote brain health as we age.

“In general, the role of friendship in our lives isn’t terribly well appreciated,” said Rebecca G. Adams, a professor of sociology at the University of North Carolina, Greensboro. “There is just scads of stuff on families and marriage, but very little on friendship. It baffles me. Friendship has a bigger impact on our psychological well-being than family relationships.”

In a new book, “The Girls From Ames: A Story of Women and a 40-Year Friendship” (Gotham), Jeffrey Zaslow tells the story of 11 childhood friends who scattered from Iowa to eight different states. Despite the distance, their friendships endured through college and marriage, divorce and other crises, including the death of one of the women in her 20s.

Using scrapbooks, photo albums and the women’s own memories, Mr. Zaslow chronicles how their close friendships have shaped their lives and continue to sustain them. The role of friendship in their health and well-being is evident in almost every chapter.

Two of the friends have recently learned they have breast cancer. Kelly Zwagerman, now a high school teacher who lives in Northfield, Minn., said that when she got her diagnosis in September 2007, her doctor told her to surround herself with loved ones. Instead, she reached out to her childhood friends, even though they lived far away.

“The first people I told were the women from Ames,” she said in an interview. “I e-mailed them. I immediately had e-mails and phone calls and messages of support. It was instant that the love poured in from all of them.”

When she complained that her treatment led to painful sores in her throat, an Ames girl sent a smoothie maker and recipes. Another, who had lost a daughter to leukemia, sent Ms. Zwagerman a hand-knitted hat, knowing her head would be cold without hair; still another sent pajamas made of special fabric to help cope with night sweats.

Ms. Zwagerman said she was often more comfortable discussing her illness with her girlfriends than with her doctor. “We go so far back that these women will talk about anything,” she said.

Ms. Zwagerman says her friends from Ames have been an essential factor in her treatment and recovery, and research bears her out. In 2006, a study of nearly 3,000 nurses with breast cancer found that women without close friends were four times as likely to die from the disease as women with 10 or more friends. And notably, proximity and the amount of contact with a friend wasn’t associated with survival. Just having friends was protective.

Bella DePaulo, a visiting psychology professor at the University of California, Santa Barbara, whose work focuses on single people and friendships, notes that in many studies, friendship has an even greater effect on health than a spouse or family member. In the study of nurses with breast cancer, having a spouse wasn’t associated with survival.

While many friendship studies focus on the intense relationships of women, some research shows that men can benefit, too. In a six-year study of 736 middle-age Swedish men, attachment to a single person didn’t appear to affect the risk of heart attack and fatal coronary heart disease, but having friendships did. Only smoking was as important a risk factor as lack of social support.

Exactly why friendship has such a big effect isn’t entirely clear. While friends can run errands and pick up medicine for a sick person, the benefits go well beyond physical assistance; indeed, proximity does not seem to be a factor.

It may be that people with strong social ties also have better access to health services and care. Beyond that, however, friendship clearly has a profound psychological effect. People with strong friendships are less likely than others to get colds, perhaps because they have lower stress levels.

Last year, researchers studied 34 students at the University of Virginia, taking them to the base of a steep hill and fitting them with a weighted backpack. They were then asked to estimate the steepness of the hill. Some participants stood next to friends during the exercise, while others were alone.

The students who stood with friends gave lower estimates of the steepness of the hill. And the longer the friends had known each other, the less steep the hill appeared.

“People with stronger friendship networks feel like there is someone they can turn to,” said Karen A. Roberto, director of the center for gerontology at Virginia Tech. “Friendship is an undervalued resource. The consistent message of these studies is that friends make your life better.”

Comments [0]

FINALLY!!!! FDA to allow 'morning-after' pill for 17-year-olds OTC!!!

Emergency Contraception is safe, legal, and available. It works-- the sooner you take the better!

Teens and women can get it at low cost or even free at some clinics.

WOMEN OF CHILDBEARING AGE:  It makes sense to get it IN ADVANCE of needing it. This way, it's ready when you need it.

1 888 NOT 2 LATE for additional information.

http://news.yahoo.com/s/ap/20090423/ap_on_he_me/us_morning_after_pill
 

Comments [0]

Dancing to Boogie Woogie -- WOWEE!

Get the Flash Playerto see this player.
(download)

Comments [0]

Women's Sexual Health Conference Sat, 4/4, NYC

Half day, only $25!
Still time to register!
http://www.twshf.com/pdf/Intimacy%20brochure.pdf
Join us!

Comments [0]